This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Shah ED, et al. Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System. Alimentary Pharmacology and Therapeutics : 28 Jan 2020. Available from: URL: http://doi.org/10.1111/apt.15637
About this article
Cite this article
Biological therapy-related hepatosplenic T-cell lymphoma. Reactions Weekly 1790, 6 (2020). https://doi.org/10.1007/s40278-020-74625-z